Professional Summary
Education & Certifications
- Board Certification: American Board of Pediatrics, Pediatrics (2024)
- Residency: Cincinnati Children's Hospital Medical Center Pediatric Residency (1995) OH
- Residency: MGM Medical College (1983) India
-
- Medical Education: MGM Medical College (1983) India
- Internship: MGM Medical College (1981) India
- MD, Indore University, Pediatrics (1983)
- M.B.B.S, Indore University (1980)
Honors & Awards
- DISTINGUISHED SERVICE AWARD, STANFORD CHILDREN'S HEALTH/LUCILE PACKARD CHILDRENS HOSPITAL (MAY14, 2018)
- Fanconi Anemia Appreciation award, Fanconi Anemia Research Fund (October 2023)
- President's award, Best Woman Candidate in India in Medical School Examinations (1979)
-
Administrative Appointments
- Clinical Director, Pediatric Stem Cell Transplant (2008 - Present)
- Section chief, Pediatric Stem Cell Transplantation (2010 - Present)
-
Publications
-
Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy
DiCarlo, J. V., Alexander, S. R., Agarwal, R., & Schiffman, J. D. (2003). Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 25(10), 801–5. -
High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: Results and prognostic indices
Lieskovsky, Y. E., Donaldson, S. S., Torres, M. A., Wong, R. M., Amylon, M. D., Link, M. P., & Agarwal, R. (2004). High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: Results and prognostic indices. JOURNAL OF CLINICAL ONCOLOGY, 22(22), 4532–40. -
Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation
Dvorak, C. C., Steinbach, W. J., Brown, J. M. Y., & Agarwal, R. (2005). Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. BONE MARROW TRANSPLANTATION, 36(7), 621–29. -
-
Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy
Deeg, H. J., O'Donnell, M., Tolar, J., Agarwal, R., Harris, R. E., Feig, S. A., … Storer, B. (2006). Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. BLOOD, 108(5), 1485–91. -
Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus
Dvorak, C. C., Callard, E., & Agarwal, R. (2006). Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus. BONE MARROW TRANSPLANTATION, 38(3), 253–254. -
SPLENIC AND HEPATIC PELIOSIS - MR FINDINGS
MAVES, C. K., CARON, K. H., Bisset, G. S., & Agarwal, R. (1992). SPLENIC AND HEPATIC PELIOSIS - MR FINDINGS. AMERICAN JOURNAL OF ROENTGENOLOGY, 158(1), 75–76. -
Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia
Dvorak, C. C., Agarwal, R., Dahl, G. V., Gregory, J. J., & Feusner, J. H. (2008). Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 14(7), 824–30. -
High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience
Agarwal, R., Dvorak, C. C., Stockerl-Goldstein, K. E., Johnston, L., & Srinivas, S. (2009). High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience. BONE MARROW TRANSPLANTATION, 43(7), 547–552. -
SAFETY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN LESS THAN THREE YEARS OF AGE
Dvorak, C. C., Wright, N. B., Wong, W. B., Kristovich, K. M., Matthews, E. W., Weinberg, K. I., … Agarwal, R. (2008). SAFETY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN LESS THAN THREE YEARS OF AGE. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 25(8), 705–22. -
Pathological evidence of Wolman's disease following hematopoietic stem cell transplantation despite correction of lysosomal acid lipase activity
Gramatges, M. M., Dvorak, C. C., Regula, D. P., Enns, G. M., Weinberg, K., & Agarwal, R. (2009). Pathological evidence of Wolman's disease following hematopoietic stem cell transplantation despite correction of lysosomal acid lipase activity. BONE MARROW TRANSPLANTATION, 44(7), 449–450. -
Nontuberculous Mycobacteria Infections in Immunocompromised Patients Single Institution Experience
Wei, M. C., Banaei, N., Yakrus, M. A., Stoll, T., Gutierrez, K. M., & Agarwal, R. (2009). Nontuberculous Mycobacteria Infections in Immunocompromised Patients Single Institution Experience. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 31(8), 556–60. -
LONG-TERM CULTURE OF CHRONIC MYELOGENOUS LEUKEMIA MARROW-CELLS ON STEM-CELL FACTOR-DEFICIENT STROMA FAVORS BENIGN PROGENITORS
Agarwal, R., Doren, S., Hicks, B., & DUNBAR, C. E. (1995). LONG-TERM CULTURE OF CHRONIC MYELOGENOUS LEUKEMIA MARROW-CELLS ON STEM-CELL FACTOR-DEFICIENT STROMA FAVORS BENIGN PROGENITORS. BLOOD, 85(5), 1306–1312. -
Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions
Sekhar, M., Kotani, H., Doren, S., Agarwal, R., McGarrity, G., & DUNBAR, C. E. (1996). Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions. HUMAN GENE THERAPY, 7(1), 33–38. -
Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation
Morris, J. D., Harris, R. E., Hashmi, R., SAMBRANO, J. E., Gruppo, R. A., Becker, A. T., & Morris, C. L. (1997). Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation. BONE MARROW TRANSPLANTATION, 20(10), 871–878. -
THE CYTOKINE RESPONSE TO HEMATOPOIETIC STEM CELL TRANSPLANTATION
Kim, P., Agarwal, R., Shah, A., Craver, L., Killen, R., Rosenberg-Hasson, Y., & DiCarlo, J. (2010). THE CYTOKINE RESPONSE TO HEMATOPOIETIC STEM CELL TRANSPLANTATION. CRITICAL CARE MEDICINE, 38(12), U80–U80. -
Single Institution Experience With Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients With Acute Leukemia
Breese, E., Agarwal, R., Kharbanda, S., Breese, M., Amylon, M., Weinberg, K. I., … Willert, J. R. (2013). Single Institution Experience With Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients With Acute Leukemia. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(2), S242–S243. -
High Risk Allogeneic Hematopoietic Cell Transplant (HCT) Patients with Any Level of Cytomegalovirus (CMV) Viremia Should Be Treated with Antiviral Therapy to Prevent Serious CMV Disease
Winestone, L., Agarwal, R., Weinberg, K. L., Porteus, M., Willerts, J. R., Amylon, M., & Kharbanda, S. (2013). High Risk Allogeneic Hematopoietic Cell Transplant (HCT) Patients with Any Level of Cytomegalovirus (CMV) Viremia Should Be Treated with Antiviral Therapy to Prevent Serious CMV Disease. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(2), S312–S312. -
Autologous Transplantation for Hodgkin disease: A Tale of Two Eras
Garfin, P. M., Luna-Fineman, S., Amylon, M., Kharbanda, S., Weinberg, K. I., Willert, J. R., … Agarwal, R. (2013). Autologous Transplantation for Hodgkin disease: A Tale of Two Eras. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(2), S247–S247. -
Hematopoietic Cell Transplantation (HCT) for Treatment of Genetic Lymphohematopoietic Diseases for Patients Lacking a Fully Matched Sibling Donor Using a Novel Conditioning Regimen
Kharbanda, S., Agarwal, R., Miklos, D. B., Porteus, M., Amylon, M., Willert, J. R., & Weinberg, K. I. (2013). Hematopoietic Cell Transplantation (HCT) for Treatment of Genetic Lymphohematopoietic Diseases for Patients Lacking a Fully Matched Sibling Donor Using a Novel Conditioning Regimen. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(2), S250–S251. -
Bortezomib As a Treatment for Autoimmune Cytopenia After Bone Marrow Transplant
Lalefar, N. R., Agarwal, R., Porteus, M. H., Kharbanda, S., & Weinberg, K. I. (2013). Bortezomib As a Treatment for Autoimmune Cytopenia After Bone Marrow Transplant. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(2), S177–S177. -
Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: Results of the first 2 years
Kwan, A., Church, J. A., Cowan, M. J., Agarwal, R., Kapoor, N., Kohn, D. B., … Puck, J. M. (2013). Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: Results of the first 2 years. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 132(1), 140–U245. -
Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells.
Kharbanda, S., Smith, A. R., Hutchinson, S. K., McKenna, D. H., Ball, J. B., Lamb, L. S., … Wagner, J. E. (2014). Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells. Biology of Blood and Marrow Transplantation , 20(4), 581–86. -
Cytokine and chemokine patterns across 100 days after hematopoietic stem cell transplantation in children.
DiCarlo, J., Agarwal-Hashmi, R., Shah, A., Kim, P., Craveiro, L., Killen, R., … Maecker, H. (2014). Cytokine and chemokine patterns across 100 days after hematopoietic stem cell transplantation in children. Biology of Blood and Marrow Transplantation , 20(3), 361–69. -
Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement.
Hiniker, S. M., Agarwal, R., Modlin, L. A., Gray, C. C., Harris, J. P., Million, L., … Donaldson, S. S. (2014). Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement. International Journal of Radiation Oncology, Biology, Physics, 89(1), 67–74. -
A Pediatric Case of T-Cell Prolymphocytic Leukemia
Mitton, B., Coutre, S., Willert, J., Schlis, K., Porteus, M., Kharbanda, S., & Agarwal-Hashmi, R. (2015). A Pediatric Case of T-Cell Prolymphocytic Leukemia. PEDIATRIC BLOOD & CANCER, 62(6), 1061–62. -
Improved outcomes after autologous bone marrow transplantation for children with relapsed or refractory hodgkin lymphoma: twenty years experience at a single institution.
Garfin, P. M., Link, M. P., Donaldson, S. S., Advani, R. H., Luna-Fineman, S., Kharbanda, S., … Agarwal-Hashmi, R. (2015). Improved outcomes after autologous bone marrow transplantation for children with relapsed or refractory hodgkin lymphoma: twenty years experience at a single institution. Biology of Blood and Marrow Transplantation , 21(2), 326–34. -
A Reduced-Toxicity Regimen Is Associated with Durable Engraftment and Clinical Cure of Nonmalignant Genetic Diseases among Children Undergoing Blood and Marrow Transplantation with an HLA-Matched Related Donor.
Mahadeo, K. M., Weinberg, K. I., Abdel-Azim, H., Miklos, D. B., Killen, R., Kohn, D., … Kapoor, N. (2015). A Reduced-Toxicity Regimen Is Associated with Durable Engraftment and Clinical Cure of Nonmalignant Genetic Diseases among Children Undergoing Blood and Marrow Transplantation with an HLA-Matched Related Donor. Biology of Blood and Marrow Transplantation , 21(3), 440–44. -
A Multidisciplinary Care Team Perspective on Children's Emotional Experience in Isolation for Stem Cell Transplantation
Savig, E. S., Gurevitch, J. H., Jackson, J. E., Malinowski, A., Ju, W. G., Leifer, L. J., … Agarwal-Hashmi, R. (2015). A Multidisciplinary Care Team Perspective on Children's Emotional Experience in Isolation for Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. San Diego. -
Invasive Fungal Disease in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Aftandilian, C., Weinberg, K., Willert, J., Kharbanda, S., Porteus, M., Maldonado, Y., & Agarwal, R. (2016). Invasive Fungal Disease in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 38(7), 574–80. -
The Cost of Hematopoietic Stem-Cell Transplantation in the United States
Broder, M. S., Quock, T. P., Chang, E., Reddy, S. R., Agarwal-Hashmi, R., Arai, S., & Villa, K. F. (2017). The Cost of Hematopoietic Stem-Cell Transplantation in the United States. AMERICAN HEALTH AND DRUG BENEFITS, 10(7), 366–73. -
Durable Engraftment, Correction of Genetic Defects and Prevention of Veno-Occlussive Disease, Following Blood and Marrow Transplantation with an HLA-Matched Sibling DONOR, Using a Reduced Toxicity Conditioning Regimen with Busulfan, Reduced Dose Cyclophos
Mahadeo, K. M., Agarwal, R., Weinberg, K. I., Abdel-Azim, H., Miklos, D. B., Shah, A. J., … Kapoor, N. (2014). Durable Engraftment, Correction of Genetic Defects and Prevention of Veno-Occlussive Disease, Following Blood and Marrow Transplantation with an HLA-Matched Sibling DONOR, Using a Reduced Toxicity Conditioning Regimen with Busulfan, Reduced Dose Cyclophos. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(2), S83. -
SINGLE INSTITUTION EXPERIENCE: COMPARISON OF HEPARIN VERSUS URSODIOL FOR PREVENTION OF VOD.
Shinn, L., Pinner, L., Kula, J., Kumar, P., Agarwal, R., & Weinberg, K. (2017). SINGLE INSTITUTION EXPERIENCE: COMPARISON OF HEPARIN VERSUS URSODIOL FOR PREVENTION OF VOD. ONCOLOGY NURSING FORUM, 44(2). -
ENDOCRINE SEQUELAE OF STEM CELL TRANSPLANTATION
Barnum, J., Agarwal, R., & Bachrach, L. (2012). ENDOCRINE SEQUELAE OF STEM CELL TRANSPLANTATION. PEDIATRIC BLOOD & CANCER, 58(7), 1022–23. -
Incidence and Mortality of Invasive Fungal Disease in Pediatric Patients after Allogeneic Stem Cell Transplant
Aftandilian, C., Agarwal, R., Kharbanda, S., & Weinberg, K. I. (2014). Incidence and Mortality of Invasive Fungal Disease in Pediatric Patients after Allogeneic Stem Cell Transplant. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Delayed Platelet Engraftment and Early Increased Creatinine after Stem Cell Transplant Predicts Sustained Remission in Pediatric Leukemia
Sridhar, M., Dvorak, C. C., Agarwal, R., & Schiffman, J. D. (2008). Delayed Platelet Engraftment and Early Increased Creatinine after Stem Cell Transplant Predicts Sustained Remission in Pediatric Leukemia. BLOOD, 112(11), 752. -
Survival and Neurocognitive Outcomes Following Cranial or Craniospinal Irradiation Plus Total Body Irradiation Prior to Transplantation in Children with CNS Leukemia
Hiniker, S. M., Agarwal, R., Modlin, L. A., Harris, J. P., Kiamanesh, E. E., Million, L., … Donaldson, S. S. (2014). Survival and Neurocognitive Outcomes Following Cranial or Craniospinal Irradiation Plus Total Body Irradiation Prior to Transplantation in Children with CNS Leukemia. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(2), S170–S171. -
END Organ Disease in the Context of Human Herpes VIRUS 6 Viremia in Pediatric Allogeneic Hematopoietic STEM CELL Transplant Patients: A Case Series
Winestone, L., Agarwal, R., Montoya, J., Weinberg, K. I., Porteus, M. H., Pinsky, B., … Kharbanda, S. (2014). END Organ Disease in the Context of Human Herpes VIRUS 6 Viremia in Pediatric Allogeneic Hematopoietic STEM CELL Transplant Patients: A Case Series. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(2), S255. -
Outcome in Pediatric Patients with a History of Fungal Disease Prior to Allogeneic Stem Cell Transplant
Aftandilian, C., Agarwal, R., Kharbanda, S., & Weinberg, K. I. (2014). Outcome in Pediatric Patients with a History of Fungal Disease Prior to Allogeneic Stem Cell Transplant. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Costs of Hematopoietic Stem Cell Transplantation and Associated Conditioning Regimens
Quock, T. P., Broder, M. S., Chang, E., Reddy, S. R., Arai, S., Agarwal-Hashmi, R., & Villa, K. F. (2016). Costs of Hematopoietic Stem Cell Transplantation and Associated Conditioning Regimens. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22(3), S282. -
Costs of Hematopoietic Stem Cell Transplantation and Associated Conditioning Regimens
Quock, T. P., Broder, M. S., Chang, E., Reddy, S. R., Arai, S., Agarwal-Hashmi, R., & Villa, K. F. (2015). Costs of Hematopoietic Stem Cell Transplantation and Associated Conditioning Regimens. BLOOD, 126(23). -
Anti-Fungal Prophylaxis Using Intermediate Dose Ambisome Is Associated with Delayed Methotrexate Clearance in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Schultz, L. M., Kumar, K., Stone, S., Callard, E., Witkowski, J., Shinn, L., … Kharbanda, S. (2016). Anti-Fungal Prophylaxis Using Intermediate Dose Ambisome Is Associated with Delayed Methotrexate Clearance in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. BLOOD, 128(22). -
Early CVVH increases survival from bone marrow transplant ARDS
DiCarlo, J. V., Alexander, Agarwal-Hashmi, R., & Schiffman, J. D. (2003). Early CVVH increases survival from bone marrow transplant ARDS. PEDIATRIC RESEARCH, 53(4), 274A–275A. -
Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017.
Amatuni, G. S., Currier, R. J., Church, J. A., Bishop, T., Grimbacher, E., Nguyen, A. A.-C., … Puck, J. M. (2019). Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017. Pediatrics. -
Administration of BPX-501 Following alpha-T and B-Cell Depleted Haplo-HSCT in Children with Transfusion-Dependent Thalassemia
Galaverna, F., Pagliara, D., Manwani, D., Agarwal, R., Kuhn, M., & Locatelli, F. (2018). Administration of BPX-501 Following alpha-T and B-Cell Depleted Haplo-HSCT in Children with Transfusion-Dependent Thalassemia. BLOOD, 132. -
Administration of BPX-501 Cells Following A beta T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias
Locatelli, F., Ruggeri, A., Merli, P., Naik, S., Agarwal, R., Aquino, V., … Kapoor, N. (2018). Administration of BPX-501 Cells Following A beta T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias. BLOOD, 132. -
Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disrase (GvHD)
Elkeky, R., Jacobsohn, D. A., Agarwal, R., Naik, S., Kapoor, N., Krishnamurti, L., … Locatelli, F. (2018). Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disrase (GvHD). BLOOD, 132. -
Related and Unrelated Donor Transplantation for beta Thalassemia Major: Results of an International Survey
Li, C., Mathews, V., George, B., Kim, S., Hebert, K., Jiang, H., … Eapen, M. (2018). Related and Unrelated Donor Transplantation for beta Thalassemia Major: Results of an International Survey. BLOOD, 132. -
Invasive Fungal Disease in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant.
Aftandilian, C., Weinberg, K., Willert, J., Kharbanda, S., Porteus, M., Maldonado, Y., & Agarwal, R. (2016). Invasive Fungal Disease in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant. Journal of Pediatric Hematology/Oncology, 38(7), 574–580. -
Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017
Amatuni, G. S., Currier, R. J., Church, J. A., Bishop, T., Grimbacher, E., Nguyen, A. A.-C., … Puck, J. M. (2019). Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017. PEDIATRICS, 143(2). -
Related and unrelated donor transplantation for ß-thalassemia major: results of an international survey.
Li, C., Mathews, V., Kim, S., George, B., Hebert, K., Jiang, H., … Eapen, M. (2019). Related and unrelated donor transplantation for ß-thalassemia major: results of an international survey. Blood Advances, 3(17), 2562–70. -
Feasibility of brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in children and adolescents (< 18 years) with early relapse Hodgkin lymphoma.
Fernandez, K. S., Mavers, M., Chang-Halpenny, C. N., Titapiwatanakun, R., Baker, K., Pugmire, B., … Agarwal-Hashmi, R. (2019). Feasibility of brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in children and adolescents (< 18 years) with early relapse Hodgkin lymphoma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
REGULATORY TYPE 1 T CELL INFUSION IN MISMATCHED RELATED OR UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR HEMATOLOGIC MALIGNANCIES
Agarwal, R., Bacchetta, R., Bertaina, A., Hu, J. C., Chen, P., Saini, G., … Roncarolo, M. G. (2019). REGULATORY TYPE 1 T CELL INFUSION IN MISMATCHED RELATED OR UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR HEMATOLOGIC MALIGNANCIES. PEDIATRIC BLOOD & CANCER. WILEY. -
Mapping the Cellular Heterogeneity of CD34-Selected Umbilical Cord Blood Products
Mantri, S., Reinisch, A., Weinberg, K., Lyell, D., DiGiusto, D., Agarwal-Hashmi, R., & Porteus, M. (2018). Mapping the Cellular Heterogeneity of CD34-Selected Umbilical Cord Blood Products. BONE MARROW TRANSPLANTATION. NATURE PUBLISHING GROUP. -
The Binns Program for Cord Blood Research: a novel program for cord blood procurement in an academic setting for biomedical research
Mantri, S., Lyell, D., DiGiusto, D., Porteus, M., & Agarwal-Hashmi, R. (2018). The Binns Program for Cord Blood Research: a novel program for cord blood procurement in an academic setting for biomedical research. BONE MARROW TRANSPLANTATION. NATURE PUBLISHING GROUP. -
Central Nervous System Relapse After Stem Cell Transplantation in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: A Single-Institution Experience.
Kozak, M. M., Yoo, C. H., Gutkin, P. M., von Eyben, R., Agarwal, R., Donaldson, S. S., … Hiniker, S. M. (2019). Central Nervous System Relapse After Stem Cell Transplantation in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: A Single-Institution Experience. Journal of Adolescent and Young Adult Oncology. -
Brentuximab Vedotin as Consolidation Therapy After Autologous Stem Cell Transplantation in Children and Adolescents (<18y) With Early Relapse Hodgkin Lymphoma.
Fernandez, K. S., Mavers, M., Marks, L. J., & Agarwal, R. (2019). Brentuximab Vedotin as Consolidation Therapy After Autologous Stem Cell Transplantation in Children and Adolescents (<18y) With Early Relapse Hodgkin Lymphoma. Journal of Pediatric Hematology/Oncology. -
A beta T-Cell/CD19 B-Cell Depleted Haploidentical Stem Cell Transplantation: A New Platform for Curing Rare and Monogenic Disorders
Bertaina, A., Bacchetta, R., Lewis, D. B., Grimm, P. C., Shah, A. J., Agarwal, R., … Roncarolo, M. G. (2020). A beta T-Cell/CD19 B-Cell Depleted Haploidentical Stem Cell Transplantation: A New Platform for Curing Rare and Monogenic Disorders. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), S288. -
Third-Party Virus-Specific T-Cell Infusion for Treatment of Refractory Viral Infections: Interim Results from PBMTC SUP1701
Keller, M. D., Hanley, P. J., Zhang, N., Tanna, J., Fatic, A., Lang, H., … Pulsipher, M. A. (2020). Third-Party Virus-Specific T-Cell Infusion for Treatment of Refractory Viral Infections: Interim Results from PBMTC SUP1701. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Early Epigenetic Immune Quantification Following Alpha/Beta T-Cell/CD19 B-Cell Depleted Haploidentical Stem Cell Transplant Correlates with CD4+T Cell Recovery at Day+100
Mayers, M., Schulze, J., Barbarito, G., Lakshmanan, U., Parkman, R., Weinberg, K. I., … Bertaina, A. (2020). Early Epigenetic Immune Quantification Following Alpha/Beta T-Cell/CD19 B-Cell Depleted Haploidentical Stem Cell Transplant Correlates with CD4+T Cell Recovery at Day+100. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), S305. -
Regulatory Type 1 T Cell Infusion in Mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies
Agarwal, R., Bacchetta, R., Bertaina, A., Chen, P., Saini, G., Shiraz, P., … Roncarolo, M. G. (2020). Regulatory Type 1 T Cell Infusion in Mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC. -
The Binns Program for Cord Blood Research: A Novel Program for Cord Blood Procurement in an Academic Setting for Biomedical Research
Sheikali, A., Mantri, S., Lyell, D., Porteus, M., & Agarwal, R. (2020). The Binns Program for Cord Blood Research: A Novel Program for Cord Blood Procurement in an Academic Setting for Biomedical Research. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), S206. -
Anti-Fungal Prophylaxis Using Intermediate Dose Ambisome is Associated with Delayed Methotrexate Clearance in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Schultz, L., Kumar, K., Stone, S., Callard, E., Witkowski, J., Shinn, L., … Kharbanda, S. (2017). Anti-Fungal Prophylaxis Using Intermediate Dose Ambisome is Associated with Delayed Methotrexate Clearance in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined Immunodeficiency
Agarwal, R., Dvorak, C. C., Kwon, H.-S., Long-Boyle, J. R., Prohaska, S. S., Brown, J. W., … Shizuru, J. A. (2019). Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined Immunodeficiency. BLOOD. AMER SOC HEMATOLOGY. -
The Binns Program for Cord Blood Research: A novel model of cord blood banking for academic biomedical research.
Mantri, S., Sheikali, A., Binns, C., Lyell, D. J., DiGiusto, D. L., Porteus, M. H., & Agarwal-Hashmi, R. (2020). The Binns Program for Cord Blood Research: A novel model of cord blood banking for academic biomedical research. Placenta, 103, 50–52. -
CD34 expression does not correlate with immunophenotypic stem cell or progenitor content in human cord blood products.
Mantri, S., Reinisch, A., Dejene, B. T., Lyell, D. J., DiGiusto, D. L., Agarwal-Hashmi, R., … Porteus, M. H. (2020). CD34 expression does not correlate with immunophenotypic stem cell or progenitor content in human cord blood products. Blood Advances, 4(21), 5357–61. -
Alloantigen-specific Tr1 cells designed to prevent GvHD have a distinct molecular identity and suppress through CTLA-4 and PD-1
Cepika, A.-M., Chen, P. P., Uyeda, M. J., Cieniewicz, B., Narula, M., Amaya, L., … Roncarolo, M. G. (2020). Alloantigen-specific Tr1 cells designed to prevent GvHD have a distinct molecular identity and suppress through CTLA-4 and PD-1. ournal for ImmunoTherapy of Cancer. -
Chimerism Analysis in Pediatric Hematopoietic Stem Cell Transplantation for Non-Malignant Disorders
Mariano, L., Zhang, B., Kristovich, K., Agarwal-Hashmi, R., Roncarolo, M. G., Bertaina, A., & Fernandez-Vina, M. (2019). Chimerism Analysis in Pediatric Hematopoietic Stem Cell Transplantation for Non-Malignant Disorders. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Administration of BPX-501 Cells Following A beta T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias (AL)
Galaverna, F., Ruggeri, A., Merli, P., Kapoor, N., Agarwal-Hashmi, R., Aquino, V., … Naik, S. (2019). Administration of BPX-501 Cells Following A beta T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias (AL). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(3). -
Regulatory Type 1 T Cell Infusion in Mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies
Agarwal, R., Bacchetta, R., Bertaina, A., Chu, J., Chen, P., Saini, G., … Roncarolo, M. G. (2019). Regulatory Type 1 T Cell Infusion in Mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Toxicity-Free Hematopoietic Stem Cell Engraftment Achieved with Anti-CD117 Monoclonal Antibody Conditioning
Agarwal, R., Dvorak, C. C., Prohaska, S., Long-Boyle, J., Kwon, H.-S., Brown, J. (W. M., … Shizuru, J. A. (2019). Toxicity-Free Hematopoietic Stem Cell Engraftment Achieved with Anti-CD117 Monoclonal Antibody Conditioning. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Gene Therapy for Fanconi Anemia [Group A]: Preliminary Results of Ongoing RP-L102 Clinical Trials
Czechowicz, A., Sevilla, J., Booth, C., Agarwal, R., Zubicaray, J., Rio, P., … Roncarolo, M. G. (2021). Gene Therapy for Fanconi Anemia [Group A]: Preliminary Results of Ongoing RP-L102 Clinical Trials. MOLECULAR THERAPY. CELL PRESS. -
Adoptively Transferred, In Vitro-Generated Alloantigen-Specific Type 1 Regulatory T (Tr1) Cells Persist Long-Term In Vivo
Cepika, A.-M., Chen, P. P., Agarwal, R., Saini, G., Louis, D. M., Amaya-Hernandez, L. C., … Roncarolo, M. G. (2021). Adoptively Transferred, In Vitro-Generated Alloantigen-Specific Type 1 Regulatory T (Tr1) Cells Persist Long-Term In Vivo. MOLECULAR THERAPY. CELL PRESS. -
Preclinical Safety and Efficacy Validation of CD4(LVFOXP3) Cells as an Innovative Cell-Based Gene Therapy Approach for IPEX Syndrome
Sato, Y., Nathan, A., Wright, J. F., Tate, K. M., Wani, P., Fazeli, F., … Bacchetta, R. (2021). Preclinical Safety and Efficacy Validation of CD4(LVFOXP3) Cells as an Innovative Cell-Based Gene Therapy Approach for IPEX Syndrome. MOLECULAR THERAPY. CELL PRESS. -
Tissue-specific telomere shortening and degenerative changes in a patient with TINF2 mutation and dyskeratosis congenita.
Roake, C. M., Juntilla, M., Agarwal-Hashmi, R., Artandi, S., & Kuo, C. S. (2021). Tissue-specific telomere shortening and degenerative changes in a patient with TINF2 mutation and dyskeratosis congenita. Human Pathology (New York), 25. -
Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients.
Chen, P. P., Cepika, A.-M., Agarwal-Hashmi, R., Saini, G., Uyeda, M. J., Louis, D. M., … Roncarolo, M. G. (2021). Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients. Science Translational Medicine, 13(617), eabf5264. -
Sequential hematopoietic stem cell transplantation (HSCT) followed by kidney transplant-3 children who received ABT-cell/CD19 B-cell depleted HSCT followed by kidney transplant from same parental donor are rejection free and immunosuppression free with donor specific tolerance > 1year post kidney transplant
Grimm, P., Lewis, D. B., Al-Uzri, A., Fathallah-Shaykh, S., Shah, A., Agarwal, R., … Bertaina, A. (2022). Sequential hematopoietic stem cell transplantation (HSCT) followed by kidney transplant-3 children who received ABT-cell/CD19 B-cell depleted HSCT followed by kidney transplant from same parental donor are rejection free and immunosuppression free with donor specific tolerance > 1year post kidney transplant. PEDIATRIC TRANSPLANTATION. WILEY. -
Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia.
Bertaina, A., Grimm, P. C., Weinberg, K., Parkman, R., Kristovich, K. M., Barbarito, G., … Lewis, D. B. (2022). Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia. The New England Journal of Medicine, 386(24), 2295–2302. -
Functional Immune Tolerance Induced By Sequential Hematopoietic Stem Cell-Solid Organ Transplantation
Bertaina, A., Barbarito, G., Ramachandran, V. V., Kristovich, K., Lippner, E. A., Fathallah-Shaykh, S., … Grimm, P. C. (2021). Functional Immune Tolerance Induced By Sequential Hematopoietic Stem Cell-Solid Organ Transplantation. BLOOD. AMER SOC HEMATOLOGY. -
Gene Therapy for Fanconi Anemia [Group A]: Interim Results of RP-L102 Clinical Trials
Czechowicz, A., Sevilla, J., Agarwal, R., Booth, C., Zubicaray, J., Rio, P., … Roncarolo, M. G. (2021). Gene Therapy for Fanconi Anemia [Group A]: Interim Results of RP-L102 Clinical Trials. BLOOD. AMER SOC HEMATOLOGY. -
Effect of Testicular Boost in Children With Leukemia Receiving Total Body Irradiation and Stem Cell Transplant: A Single-Institution Experience
Blomain, E. S., Jiang, A., Donaldson, S. S., Agarwal, R., Bertaina, A., Shyr, D., … Oh, J. (2023). Effect of Testicular Boost in Children With Leukemia Receiving Total Body Irradiation and Stem Cell Transplant: A Single-Institution Experience. ADVANCES IN RADIATION ONCOLOGY, 8(1). -
Effect of Testicular Boost in Children With Leukemia Receiving Total Body Irradiation and Stem Cell Transplant: A Single-Institution Experience.
Blomain, E. S., Jiang, A., Donaldson, S. S., Agarwal, R., Bertaina, A., Shyr, D., … Oh, J. (2023). Effect of Testicular Boost in Children With Leukemia Receiving Total Body Irradiation and Stem Cell Transplant: A Single-Institution Experience. Advances in Radiation Oncology, 8(1), 101071. -
Hematopoietic and Immunological Assessment in Fanconi Anemia after Ex Vivo Lentiviral FANCA Gene Therapy with RP-L102
Nofal, R., Chan, Y. Y., Sen, S., Figueroa, U. J., Willner, H., Felber, M., … Czechowicz, A. (2022). Hematopoietic and Immunological Assessment in Fanconi Anemia after Ex Vivo Lentiviral FANCA Gene Therapy with RP-L102. BLOOD. AMER SOC HEMATOLOGY. -
Lentiviral-mediated Gene Therapy for Patients with Fanconi Anemia [Group A]: Updated Results from Global RP-L102 Clinical Trials
Czechowicz, A., Sevilla, J., Booth, C., Agarwal, R., Zubicaray, J., Rio, P., … Bueren, J. A. (2022). Lentiviral-mediated Gene Therapy for Patients with Fanconi Anemia [Group A]: Updated Results from Global RP-L102 Clinical Trials. BLOOD. AMER SOC HEMATOLOGY. -
Precision Delivery of Steroids as a Rescue Therapy for Gastrointestinal Graft-versus-Host Disease in Pediatric Stem Cell Transplant Recipients
Levitte, steven, Ganguly, A., Frolik, S., & Guevara-Tique, A. (2023). Precision Delivery of Steroids as a Rescue Therapy for Gastrointestinal Graft-versus-Host Disease in Pediatric Stem Cell Transplant Recipients. Journal of Clinical Medicine, 12(4229). -
LENTIVIRAL-MEDIATED GENE THERAPY FOR FANCONI ANEMIA [GROUP A]: RESULTS FROM RP-L102 CLINICAL TRIALS
Czechowicz, A., Sevilla, J., Booth, C., Agarwal, R., Zubicaray, J., Rio, P., … Bueren, J. (2023). LENTIVIRAL-MEDIATED GENE THERAPY FOR FANCONI ANEMIA [GROUP A]: RESULTS FROM RP-L102 CLINICAL TRIALS. PEDIATRIC BLOOD & CANCER. WILEY. -
Lentiviral-Mediated Gene Therapy for Fanconi Anemia [Group A]: Results from Global RP-L102 Clinical Trials
Czechowicz, A., Sevilla, J., Booth, C., Navarro, S., Agarwal, R., Zubicaray, J., … Bueren, J. A. (2023). Lentiviral-Mediated Gene Therapy for Fanconi Anemia [Group A]: Results from Global RP-L102 Clinical Trials. MOLECULAR THERAPY. CELL PRESS. -
LENTIVIRAL-MEDIATED GENE THERAPY FOR PATIENTS WITH FANCONI ANEMIA [GROUP A]: UPDATED RESULTS FROM GLOBAL RP-L102 CLINICAL TRIALS
Sevilla, J., Booth, C., Czechowicz, A., Agarwal, R., Zubicaray, J., Rio, P., … Bueren, J. (2023). LENTIVIRAL-MEDIATED GENE THERAPY FOR PATIENTS WITH FANCONI ANEMIA [GROUP A]: UPDATED RESULTS FROM GLOBAL RP-L102 CLINICAL TRIALS. BONE MARROW TRANSPLANTATION. SPRINGERNATURE. -
Radiation and Busulfan-Free Hematopoietic Stem Cell Transplantation Using Briquilimab (JSP191) Anti-CD117 Antibody-Conditioning, Transient Immunosuppression and TCR a ß + T-Cell/CD19+B-Cell Depleted Haploidentical Grafts in Patients with Fanconi Anemia
Agarwal, R., Bertaina, A., Soco, C. F., Saini, G., Kunte, N., Hiroshima, L., … Czechowicz, A. (2023). Radiation and Busulfan-Free Hematopoietic Stem Cell Transplantation Using Briquilimab (JSP191) Anti-CD117 Antibody-Conditioning, Transient Immunosuppression and TCR a ß + T-Cell/CD19+B-Cell Depleted Haploidentical Grafts in Patients with Fanconi Anemia. BLOOD. AMER SOC HEMATOLOGY. -
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.
Keller, M. D., Hanley, P. J., Chi, Y.-Y., Aguayo-Hiraldo, P., Dvorak, C. C., Verneris, M. R., … Pulsipher, M. A. (2024). Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment. Nature Communications, 15(1), 3258. -
Lentiviral-Mediated Gene Therapy (RP-L102) for Fanconi Anemia [Group A], is Associated with Polyclonal Integration Patterns in the Absence of Conditioning
Czechowicz, A., Sevilla, J., Booth, C., Agarwal, R., Zubicaray, J., Rio, P., … Bueren, J. A. (2024). Lentiviral-Mediated Gene Therapy (RP-L102) for Fanconi Anemia [Group A], is Associated with Polyclonal Integration Patterns in the Absence of Conditioning. MOLECULAR THERAPY. CELL PRESS.
-
Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab
- CD4^LVFOXP3 in Participants With IPEX
- Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
- Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation
- Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT
- Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes
- Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
- Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders
- Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
- Gene Therapy for Fanconi Anemia, Complementation Group A
- Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses
Practice Locations
LPCH- Stem Cell Transplant (Palo Alto) Palo Alto, CA
Palo Alto, CAImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records